Your browser doesn't support javascript.
loading
A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma.
Davis, Elizabeth J; Chugh, Rashmi; Zhao, Lili; Lucas, David R; Biermann, J Sybil; Zalupski, Mark M; Feng, Mary; Wong, Sandra L; Jacobson, Jon; Zyczynski, Laurie; Reinke, Denise; Metko, Gino; Baker, Laurence H; Schuetze, Scott M.
Afiliação
  • Davis EJ; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, United States.
  • Chugh R; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, United States.
  • Zhao L; Department of Biostatistics, University of Michigan, Ann Arbor, MI, United States.
  • Lucas DR; Department of Pathology, University of Michigan, Ann Arbor, MI, United States.
  • Biermann JS; Department of Surgery, University of Michigan, Ann Arbor, MI, United States.
  • Zalupski MM; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, United States.
  • Feng M; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, United States.
  • Wong SL; Department of Surgery, University of Michigan, Ann Arbor, MI, United States.
  • Jacobson J; Department of Radiology, University of Michigan, Ann Arbor, MI, United States.
  • Zyczynski L; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, United States.
  • Reinke D; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, United States.
  • Metko G; Clinical Trials Office, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, United States.
  • Baker LH; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, United States.
  • Schuetze SM; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, United States. Electronic address: scotschu@med.umich.edu.
Eur J Cancer ; 51(13): 1794-802, 2015 Sep.
Article em En | MEDLINE | ID: mdl-26066736

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies País/Região como assunto: America do norte Idioma: En Revista: Eur J Cancer Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Neoadjuvante Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies País/Região como assunto: America do norte Idioma: En Revista: Eur J Cancer Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido